Diabetes Atherosclerosis Intervention Study (DAIS): quantitative coronary angiographic analysis of coronary artery atherosclerosis.

P R McLaughlin, P Gladstone
{"title":"Diabetes Atherosclerosis Intervention Study (DAIS): quantitative coronary angiographic analysis of coronary artery atherosclerosis.","authors":"P R McLaughlin,&nbsp;P Gladstone","doi":"10.1002/(sici)1097-0304(199807)44:3<249::aid-ccd1>3.0.co;2-5","DOIUrl":null,"url":null,"abstract":"<p><p>The primary objective of the Diabetes Atherosclerosis Intervention Study (DAIS) is to determine by quantitative coronary angiography whether long-term correction of the dyslipoproteinemia of diabetes with micronized fenofibrate results in evidence of decreased progression or regression of angiographically measured obstructive coronary atherosclerosis. The purpose of this communication is to describe the angiographic methodology for the DAIS project, and to present data documenting the reproducibility of measurements that will determine the primary outcome of DAIS. Four hundred eighteen subjects between the ages of 40 and 65 were entered from 11 centers in Canada, France, Finland, and Sweden, with 305 males and 113 females. Thirty-two percent of subjects had undergone a previous coronary artery intervention, either PTCA or bypass grafting. Subjects underwent coronary arteriography at baseline according to a strictly defined protocol. The coronary tree was divided into AHA segments and quantitative analysis of segments was performed using the cardiovascular measurement system described by Reiber. Geometric parameters including mean lumen diameter, minimum lumen diameter, maximum lumen diameter, and segment length were determined. In 15 studies, measurements were carried out on the same frame by two observers, and at least 1 week apart by the same observer. In 13 studies, measurements were performed by the same observer on two separate injections of the same coronary artery. The mean of the standard deviation of the differences of measurements of all segments for the primary study analyst was 0.029 mm, with a mean of correlation coefficients of 1.00. Between two observers, the mean of the standard deviations of segmental mean lumen diameters was 0.347 mm with a mean of coefficients of variation of 0.78. The mean of standard deviations for measurements of segmental mean lumen diameter from two separate coronary injections was 0.122, with a mean of correlation coefficients of 0.94. The mean of correlation coefficients for minimum lumen diameter were 0.98 for intraobserver variability, 0.77 for inter-observer variability, and 0.96 for inter-angiogram variability. For segment length the corresponding values were 0.99, 0.79, and 0.94. These data demonstrate that a high level of reproducibility and precision may be achieved in a multicenter study in assessment of the coronary tree in carefully performed studies using this methodology. We anticipate the results will provide a statistically powerful conclusion with new and unique data to answer the question of the effect of long-term correction of dyslipoproteinemia on coronary atherosclerosis in type II diabetic patients with dyslipoproteinemia.</p>","PeriodicalId":9664,"journal":{"name":"Catheterization and cardiovascular diagnosis","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(sici)1097-0304(199807)44:3<249::aid-ccd1>3.0.co;2-5","citationCount":"25","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Catheterization and cardiovascular diagnosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/(sici)1097-0304(199807)44:3<249::aid-ccd1>3.0.co;2-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 25

Abstract

The primary objective of the Diabetes Atherosclerosis Intervention Study (DAIS) is to determine by quantitative coronary angiography whether long-term correction of the dyslipoproteinemia of diabetes with micronized fenofibrate results in evidence of decreased progression or regression of angiographically measured obstructive coronary atherosclerosis. The purpose of this communication is to describe the angiographic methodology for the DAIS project, and to present data documenting the reproducibility of measurements that will determine the primary outcome of DAIS. Four hundred eighteen subjects between the ages of 40 and 65 were entered from 11 centers in Canada, France, Finland, and Sweden, with 305 males and 113 females. Thirty-two percent of subjects had undergone a previous coronary artery intervention, either PTCA or bypass grafting. Subjects underwent coronary arteriography at baseline according to a strictly defined protocol. The coronary tree was divided into AHA segments and quantitative analysis of segments was performed using the cardiovascular measurement system described by Reiber. Geometric parameters including mean lumen diameter, minimum lumen diameter, maximum lumen diameter, and segment length were determined. In 15 studies, measurements were carried out on the same frame by two observers, and at least 1 week apart by the same observer. In 13 studies, measurements were performed by the same observer on two separate injections of the same coronary artery. The mean of the standard deviation of the differences of measurements of all segments for the primary study analyst was 0.029 mm, with a mean of correlation coefficients of 1.00. Between two observers, the mean of the standard deviations of segmental mean lumen diameters was 0.347 mm with a mean of coefficients of variation of 0.78. The mean of standard deviations for measurements of segmental mean lumen diameter from two separate coronary injections was 0.122, with a mean of correlation coefficients of 0.94. The mean of correlation coefficients for minimum lumen diameter were 0.98 for intraobserver variability, 0.77 for inter-observer variability, and 0.96 for inter-angiogram variability. For segment length the corresponding values were 0.99, 0.79, and 0.94. These data demonstrate that a high level of reproducibility and precision may be achieved in a multicenter study in assessment of the coronary tree in carefully performed studies using this methodology. We anticipate the results will provide a statistically powerful conclusion with new and unique data to answer the question of the effect of long-term correction of dyslipoproteinemia on coronary atherosclerosis in type II diabetic patients with dyslipoproteinemia.

糖尿病动脉粥样硬化干预研究(DAIS):定量冠状动脉粥样硬化的冠状动脉造影分析。
糖尿病动脉粥样硬化干预研究(DAIS)的主要目的是通过定量冠状动脉造影来确定,用微细化非诺贝特长期纠正糖尿病的脂蛋白异常血症,是否会减少血管造影测量的阻塞性冠状动脉粥样硬化的进展或消退。本通讯的目的是描述DAIS项目的血管造影方法,并提供记录测量结果可重复性的数据,这些测量结果将决定DAIS的主要结果。来自加拿大、法国、芬兰和瑞典11个中心的418名年龄在40至65岁之间的受试者,其中男性305名,女性113名。32%的受试者之前接受过冠状动脉介入治疗,无论是PTCA还是旁路移植术。受试者在基线时根据严格定义的方案进行冠状动脉造影。采用Reiber描述的心血管测量系统将冠状动脉树划分为AHA节段,并对节段进行定量分析。几何参数包括平均管腔直径、最小管腔直径、最大管腔直径和节段长度。在15项研究中,测量由两名观察者在同一框架上进行,并且由同一观察者间隔至少1周。在13项研究中,同一观察者对同一冠状动脉的两次不同注射进行了测量。主要研究分析的所有部分测量差异的标准差均值为0.029 mm,相关系数均值为1.00。在两个观察者之间,节段平均管腔直径的标准差均值为0.347 mm,变异系数均值为0.78。两次单独冠状动脉注射测量的节段性平均管腔直径的标准差平均值为0.122,相关系数平均值为0.94。最小管腔直径的相关系数平均值为观察者内变异性0.98,观察者间变异性0.77,血管造影间变异性0.96。对于片段长度,对应值分别为0.99、0.79和0.94。这些数据表明,在多中心研究中,在仔细执行的研究中,使用这种方法评估冠状动脉树可以达到高水平的可重复性和精确性。我们期望这些结果将提供一个具有统计学意义的强有力的结论,以新的和独特的数据来回答长期纠正异常脂蛋白血症对II型糖尿病合并异常脂蛋白血症患者冠状动脉粥样硬化的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信